These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26444056)

  • 1. Cardioprotection and arrhythmias, Part I.
    Baczkó I; Jost N; Varró A
    Can J Physiol Pharmacol; 2015 Jul; 93(7):v. PubMed ID: 26444056
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes.
    Bian JS; Yong QC; Pan TT; Feng ZN; Ali MY; Zhou S; Moore PK
    J Pharmacol Exp Ther; 2006 Feb; 316(2):670-8. PubMed ID: 16204473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of endogenous oxytocin in cardiac ischemic preconditioning.
    Alizadeh AM; Faghihi M; Sadeghipour HR; Mohammadghasemi F; Khori V
    Regul Pept; 2011 Feb; 167(1):86-90. PubMed ID: 21130120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is oxytocin a therapeutic factor for ischemic heart disease?
    Alizadeh AM; Mirzabeglo P
    Peptides; 2013 Jul; 45():66-72. PubMed ID: 23659864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of cardiac M3 muscarinic acetylcholine receptors has cardioprotective effects against ischaemia-induced arrhythmias.
    Wang S; Han HM; Jiang YN; Wang C; Song HX; Pan ZY; Fan K; Du J; Fan YH; Du ZM; Liu Y
    Clin Exp Pharmacol Physiol; 2012 Apr; 39(4):343-9. PubMed ID: 22224440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotection and arrhythmias, Part 2.
    Baczkó I; Jost N; Varró A
    Can J Physiol Pharmacol; 2015 Sep; 93(9):v. PubMed ID: 26444207
    [No Abstract]   [Full Text] [Related]  

  • 7. Gap junctions in preconditioning against arrhythmias.
    Lascano EC; Negroni JA
    Cardiovasc Res; 2007 Jun; 74(3):341-2. PubMed ID: 17459356
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardioprotection by volatile anesthetics.
    Bienengraeber MW; Weihrauch D; Kersten JR; Pagel PS; Warltier DC
    Vascul Pharmacol; 2005; 42(5-6):243-52. PubMed ID: 15922257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical translation of cardioprotective strategies : report and recommendations of the Hatter Institute 5th International Workshop on Cardioprotection.
    Hausenloy DJ; Yellon DM
    Basic Res Cardiol; 2008 Sep; 103(5):493-500. PubMed ID: 18600363
    [No Abstract]   [Full Text] [Related]  

  • 10. Preventive use of N-3 fatty acids.
    Harris WS; O'Keefe JH
    Circulation; 2003 Nov; 108(19):e139; author reply e139. PubMed ID: 14610002
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardioprotection by volatile anesthetics: established scientific principle or lingering clinical uncertainty?
    Pagel PS
    J Cardiothorac Vasc Anesth; 2009 Oct; 23(5):589-93. PubMed ID: 19789055
    [No Abstract]   [Full Text] [Related]  

  • 12. Preconditioning with Porphyromonas gingivalis lipopolysaccharide may confer cardioprotection and improve recovery of the electrically induced intracellular calcium transient during ischemia and reperfusion.
    Fan MH; Wong KL; Wu S; Leung WK; Yam WC; Wong TM
    J Periodontal Res; 2010 Feb; 45(1):100-8. PubMed ID: 19602110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of levosimendan and milrinone on regional myocardial ischemia/reperfusion-induced arrhythmias in dogs.
    Papp JG; Pollesello P; Varró AF; Végh AS
    J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):129-35. PubMed ID: 16891290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiomyopathy.
    Purcell JA; Holder CK
    Am J Nurs; 1989 Jan; 89(1):57-74B. PubMed ID: 2642662
    [No Abstract]   [Full Text] [Related]  

  • 15. Endogenous cannabinoids contribute to remote ischemic preconditioning via cannabinoid CB2 receptors in the rat heart.
    Hajrasouliha AR; Tavakoli S; Ghasemi M; Jabehdar-Maralani P; Sadeghipour H; Ebrahimi F; Dehpour AR
    Eur J Pharmacol; 2008 Jan; 579(1-3):246-52. PubMed ID: 17950273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. eComment: Individualization of blood cardioplegia administration mode.
    Apostolakis E; Koniari I; Dougenis D
    Interact Cardiovasc Thorac Surg; 2009 May; 8(5):521-2; discussion 522. PubMed ID: 19380339
    [No Abstract]   [Full Text] [Related]  

  • 17. eComment: Re: Is repeated administration of blood-cardioplegia really necessary?
    Bockeria LA
    Interact Cardiovasc Thorac Surg; 2009 May; 8(5):522; discussion 523. PubMed ID: 19380340
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic pharmacological preconditioning against ischemia.
    Luca MC; Liuni A; Muxel S; Münzel T; Forconi S; Gori T; Parker JD
    Clin Hemorheol Microcirc; 2011; 49(1-4):287-93. PubMed ID: 22214700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propofol and cardioprotection against arrhythmias.
    Siracusano L; Girasole V
    Anesthesiology; 2009 Aug; 111(2):447-8; author reply 448. PubMed ID: 19625810
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardioprotection by ischemic postconditioning during surgical procedures.
    Sadat U; Walsh SR; Varty K
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):999-1006. PubMed ID: 18666850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.